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Antipyrine (At) and dipyrone (Dp) delay gastric emptying (GE) in
rats. The objective of the present study was to assess the effects of
intravenous (iv) and intracerebroventricular (icv) administration of At
and Dp on the GE of liquid by rats. GE was assessed in male Wistar
rats (5-10 in each group) 10 min after the icv or iv drug injection by
measuring percent gastric retention (%GR) of a saline test meal
labeled with phenol red 10 min after administration by gavage. The At
iv group was significantly higher (64.4 ± 2.6%) compared to control
(33.4 ± 1.5%) but did not differ from the Dp group (54.3 ± 3.8%).
After icv administration of At, %GR (34.2 ± 2%) did not differ from
control (32.6 ± 1.9%), but was significantly higher after Dp (54.5 ±
2.3%). Subdiaphragmatic vagotomy significantly reduced %GR in
the At group (30.2 ± 0.7%) compared to the sham group, but was
significantly higher than in the controls (23.0 ± 0.5%). In the animals
treated with At iv, baclofen significantly reduced %GR (28.3 ± 2.4%)
compared to vehicle-treated animals (55.2 ± 3.2%). The same oc-
curred in the animals treated iv with vehicle and icv with baclofen.
Although vagotomy and baclofen reduced %GR per se, the reduction
was twice more marked in the animals treated with At. The results
suggest that At administered iv, but not icv, delays GE of liquid in rats
with the participation, at least in part, of the vagus nerve and that this
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Gastric emptying (GE) is the process of
the transfer of the gastric content to the small
intestine as the result of the motor activity of
the stomach, pylorus and duodenum under
control of inhibitory and stimulatory mechan-
isms (1).
Non-steroidal anti-inflammatory drugs
are among the most frequently prescribed
drugs in the world and have been extensively
studied because of their gastrointestinal tox-
icity. Among the effects of these medica-
tions, changes in GE have been reported to
be induced by aspirin, acetaminophen and
indomethacin (2-6). Dipyrone (Dp), a phen-
ylpyrazolone derivative mainly used for its
antipyretic and analgesic properties, causes
delayed GE in rats when administered at
high doses (7). This effect was confirmed
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using a dose of 80 mg/kg (240 µmol/kg)
administered intravenously (iv) and saline
solution as a test meal (8). A recent study in
which Dp was administered iv and intracere-
broventricularly (icv) to rats has suggested
that this effect may be due to the action of the
drug on the central nervous system (CNS),
with the participation of the paraventricular
nucleus and of the vagus nerve (9). Addi-
tional observations have demonstrated that
this phenomenon is blocked by icv adminis-
tration of baclofen (bac), a GABAB receptor
agonist (10).
Takanaka et al. (11), in a study on the
effect of antipyrine (At, phenazone), an-
other phenylpyrazolone derivative, on the
GE of rats, observed delayed GE after its
administration. However, the site of action
and the mechanisms involved in this phe-
nomenon are unknown.
The objective of the present study was to
assess the effect of At on the GE of rats,
using saline solution as a test meal. The
following procedures were carried out: 1)
comparative studies with Dp using equiva-
lent doses administered iv (240 µmol/kg)
and icv (4 µmol/animal); 2) study of the
dose-response effect and time-response ef-
fect of At administered iv; 3) study of the
effect of subdiaphragmatic vagotomy (VgX)
on the iv administration of the drug; 4) study
of the effect of icv administration of bac on
the iv administration of the drug.
Material and Methods
The study was conducted on 8-week-old
male Wistar rats weighing 250-300 g, adapt-
ed to laboratory conditions for 4 weeks and
receiving water and food ad libitum. The
experimental protocols used in the present
study followed the recommendations of the
Brazilian College of Animal Experimenta-
tion (COBEA).
The drugs used, dipyrone, antipyrine, and
baclofen (all from Sigma, St. Louis, MO,
USA) were diluted in sterile physiological
saline as a vehicle at the time of the experi-
ments.
The GE test was carried out in animals
fasted for 24 h but with free access to water,
which was removed 30 min before the ex-
periments.
For the comparative study of At and Dp
injected iv the animals were divided into
three groups: At and Dp groups, respective-
ly receiving iv 45.17 and 80 mg/kg of the
drug corresponding to the dose of 240 µmol/
kg, and control group (C) receiving vehicle
(1 mL/kg body weight). Drugs were injected
iv through a tail vein and GE was assessed 10
min after administration.
For the assessment of the effect of At and
Dp administered icv, a cannula was implanted
into the right lateral ventricle of each animal
8 days before the experiments using previ-
ously established coordinates (9,10). For icv
injection, 10 µL saline (C), Dp (4 µmol =
1333.2 µg), or At (4 µmol = 752.8 µg) was
used. The dose (in µmol) and the technique
employed for icv administration had been
established in a previous study (9). GE was
assessed 10 min after the end of the icv
injection.
For the study of the dose-response effect,
iv doses of 60 (11.25 mg/kg), 120 (22.5 mg/
kg), and 240 µmol/kg (45.17 mg/kg) At were
used. Control animals (C) received vehicle
by the same route. GE was assessed 10 min
after administration. For the study of the
time-response effect, At or vehicle was ad-
ministered iv at the dose of 240 µmol/kg
(45.17 mg/kg), and GE was assessed 10, 30,
60, and 120 min after administration.
To assess the participation of the vagus
nerve in the effect of At on GE, the rats were
submitted to subdiaphragmatic section of
the ventral and dorsal branches of the vagus
(VgX group) 2 weeks before the experi-
ment. The sham group consisted of rats sub-
mitted to surgery without section of the va-
gal branches. Each group was divided into
subgroups of animals receiving vehicle (C)
or At at the dose of 240 µmol/kg (45.17 mg/
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kg) iv. GE was assessed 10 min after admin-
istration.
To assess the action of bac on the effect
of At, a solution of 2 µg bac (bac2) or vehicle
(bac0) was applied icv (10 µL) and the ani-
mals then received a solution of At, 240
µmol/kg, or vehicle (C) iv. The baclofen
dose and the technique employed for icv
administration had been established in a pre-
vious study (10). GE was assessed 10 min
after the end of the iv injection.
In all experiments, GE was evaluated
indirectly by measuring percent gastric re-
tention (%GR) of a saline test meal labeled
with phenol red (60 µg/mL) in a volume of 2
mL/100 g body weight administered by ga-
vage using a standardized technique (12).
The absorbance of the dye was determined
with a spectrophotometer at 560 nm. At the
end of the experiment all animals were sac-
rificed and the brain of those submitted to
icv injection was injected with 10 mL 1%
Evans blue through the cannula. The brain
was removed and fixed in 10% formalin for
24 h. After fixation, coronal sections were
obtained and the proper site of injection was
confirmed when the dye was observed in the
fourth ventricle.
Statistical analysis
Data are reported as means ± SEM. Sta-
tistical analysis was carried out using
ANOVA followed by the Tukey test when
necessary. When it was not possible to use
parametric tests, the Kruskal-Wallis test was
used, followed by the multiple comparisons
Dunn test when necessary. The level of sig-
nificance was set at α = 5% for all tests.
Results
The data regarding the effect of Dp and
At administered iv are presented in Figure
1A. The At and Dp groups presented a sig-
nificantly more elevated %GR compared to
control. The At group showed higher %GR
values (mean ± SEM = 64.4 ± 2.6%) which,
however, did not differ significantly from
Dp (54.3 ± 3.8%). The data regarding the
effect of Dp and At administered icv are
presented in Figure 1B. There was a signifi-
cant increase in %GR in the Dp group (54.5 ±
2.3%) compared to the C (32.6 ± 1.9%) and At
(34.2 ± 2%) groups, whereas the At group did
not differ significantly from control.
The dose-response study (Figure 2A)
showed a dose-dependent increase in %GR
in the animals treated with At (r = 0.86)
which, however, was significant only at the
dose of 240 µmol/kg (64.5 ± 4.7%) com-
pared to control (37.4 ± 1.2%). Regarding
the time-response study, the At group showed
a maximum effect of the drug on %GR at 10
min (67.6 ± 3%) compared to control (37.4 ±
1.3%). A progressive reduction occurred,
with the maintenance of a significant differ-
ence from control at 30 and 60 min which,
however, no longer existed at 120 min (Fig-
ure 2B).
Figure 1. Gastric retention of a
saline test meal 10 min after ad-
ministration to rats by gavage.
A, Ten minutes before the evalu-
ation of gastric retention, the
animals received intravenous
(iv) vehicle (C) or 240 µmol/kg
dipyrone (Dp; 80 mg/kg), or 240
µmol/kg antipyrine (At; 45.17
mg/kg). B, Eight days before the
test, a metal cannula was im-
planted into the right lateral ven-
tricle of each rat. The animals
received intracerebroventricular
(icv) 10 µL of vehicle (C) or an
equal volume of a solution con-
taining 4 µmol (1333.2 µg) Dp or
4 µmol (752.8 µg) At. Gastric
retention was assessed 10 min
after the icv injections. Data are
reported as means ± SEM for
10 animals per group. *P < 0.05
for the comparisons indicated
by the arrows (Tukey test).
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3B. The bac0At group presented a signifi-
cantly higher %GR (55.2 ± 3.2%) compared
to the bac0C group (34.0 ± 1.8%). On the
other hand, the %GR of the bac2At group
(28.3 ± 2.4%) did not differ significantly
from control (bac2C, 25.2 ± 3.2%). Baclofen
administered icv significantly reduced %GR
in the animals that received At iv (bac2At vs
bac0At) and in the control groups that re-
ceived saline iv (bac2C vs bac0C); however,
the reduction was approximately twice higher
in the animals receiving At (a 48.7% reduc-
tion in mean %GR) compared to control (a
26.1% reduction in mean %GR).
Discussion
We observed in the present study that
antipyrine administered iv delayed GE of
liquids in rats in a dose-dependent manner, a
phenomenon that differed from the effect
observed with dipyrone. First, the effect of
antipyrine was more intense during the first
10 min after iv administration, whereas the
effect of dipyrone was approximately con-
stant during the first hour (9). Second, when
the drug was administered icv it did not
change GE, indicating that it has no direct
effect on the CNS, in contrast to what was
observed with the administration of dipy-
rone. These facts suggest that the two drugs,
although having a common chemical origin
as phenylpyrazolone derivatives, cause de-
layed GE by distinct mechanisms.
After per os administration to humans,
antipyrine is rapidly and fully absorbed and
is then slowly metabolized, with a mean
plasma clearance rate of 6% per hour (13).
The hepatic isoenzymes of cytochrome P450
participate in these metabolic processes, giv-
ing origin to metabolites which are mainly
eliminated through the kidneys (14,15). If
we assume that the observed delay in GE is
due to the action of antipyrine and not of its
metabolites, it is not clear why the drug,
which continues to circulate and whose clear-
ance is slow, has the most pronounced effect
In the study of the participation of the
vagus nerve (Figure 3A) the animals of the
sham group which received At presented a
significant increase in %GR (57.9 ± 0.8%)
compared to control (29.4 ± 0.8%). Although
vagotomy reduced %GR in the animals
treated with At (30.2 ± 0.7%), the difference
was significant compared to the controls
receiving vehicle (23.0 ± 0.5%). Vagotomy
significantly reduced %GR in the animals
treated with At compared to the sham group
(VgXAt vs shamAt) and the same phenome-
non was observed among the animals that
received vehicle (VgXC vs shamC); how-
ever, the reduction was twice higher in the
animals that received At (a 47.8% reduction
in mean %GR) compared to control (a 23.8%
reduction in mean %GR).
The results of the action of icv baclofen
on the effect of iv At are presented in Figure
Figure 2. Gastric retention of a
saline test meal 10 min after ad-
ministration to rats by gavage.
A, Ten minutes before the evalu-
ation of gastric retention, the ani-
mals received iv vehicle (C) or
60 (11.25 mg/kg), 120 (22.5 mg/
kg) and 240 µmol/kg (45.17 mg/
kg) antipyrine (At). B, Ten, 30,
60, and 120 min before the
evaluation of gastric retention
the animals received iv vehicle
(C) or 240 µmol/kg (45.17 mg/
kg) At. Data are reported as
means ± SEM for 5 animals per
group. *P < 0.05 for the com-
parisons indicated by the arrows
(Tukey test).
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on GE 10 min after administration. Two
possibilities may be proposed to explain this
discrepancy: 1) The drug is inactivated or
gradually metabolized at the site where it
induces the delay, or 2) the mechanism that
antagonizes the effect of delayed GE is able
to partially counterbalance the effect of anti-
pyrine.
Subdiaphragmatic vagotomy is known
to modify the motor activity of the stomach,
blocking the arrival of afferent stimuli to the
tractus solitarius and of stimulating and in-
hibitory efferents originating from the dor-
sal nucleus of the vagus (16-18). In the
present study, vagotomy reduced the effect
on GE induced by iv administration of anti-
pyrine, suggesting the participation of vagal
pathways in this phenomenon. Since this
procedure did not fully abolish the effect, we
may conclude that the drug acts by a mech-
anism that does not depend, at least in part,
on the participation of the vagus nerve.
In addition, the effect of iv antipyrine on
GE was blocked by icv baclofen. The activa-
tion of GABAB receptors by baclofen in the
CNS results in hyperpolarization of the post-
synaptic membranes or in inhibition of neu-
rotransmitter release at presynaptic nerve
endings (19,20). There is strong evidence
that GABA, through GABAB receptors, may
participate in the control of gastric secretion
and gastrointestinal motility at the level of
the nucleus tractus solitarii (19,21-26). On
this basis, we may speculate that the stimula-
tion of presynaptic GABAB receptors by
baclofen, by blocking the excitation of the
non-adrenergic cholinergic (inhibitory) path-
way and/or the inhibition of the cholinergic
(stimulatory) pathway of the vagus deter-
mined by antipyrine, may explain the results
of the present study. Probably this is not the
only hypothesis if we consider that vagotomy
and baclofen administration in the CNS re-
duced %GR per se, although the reduction
was twice more marked in the animals that
received antipyrine. On the basis of the pres-
ent results, no other speculations would be
valid here.
The present results suggest that antipy-
rine administered iv, but not icv, delays GE
of liquid in rats with the participation, at
least in part, of the vagus nerve and that this
phenomenon is blocked by the activation of
GABAB receptors in the CNS.
Figure 3. Gastric retention of a
saline test meal 10 min after ad-
ministration to rats by gavage.
A, Two weeks before the test
the animals were submitted to
sham surgery (Sham group) or
to subdiaphragmatic vagotomy
(VgX group). Ten minutes be-
fore the evaluation of gastric re-
tention the animals of each
group received intravenous (iv)
vehicle (C) or 240 µmol/kg
(45.17 mg/kg) antipyrine (At). B,
Eight days before the test, a
metal cannula was implanted
into the right lateral ventricle of
each rat. The animals received
an intracerebroventricular (icv)
injection of 10 µL vehicle (bac0)
or an equal volume of solution
containing 2 µg baclofen (bac2)
injected over a period of 30 s,
followed by iv vehicle (C), or a
solution of At, 240 µmol/kg
(45.17 mg/kg). Gastric retention
was assessed 10 min after the
end of the iv injection. Data are
reported as means ± SEM for 10
animals per group. *P < 0.05 for
the comparisons indicated by
the arrows (Dunn test).
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